NGS 기반 RNA 시퀀스 시장 규모, 점유율 및 성장 분석 : 서비스 유형별, 아웃소싱 형태별, 기업 유형별, 용도별, 업종별, 지역별 - 업계 예측(2026-2033년)

Global Ngs-Based Rna-Sequencing Market size was valued at USD 4.2 Billion in 2024 and is poised to grow from USD 4.98 Billion in 2025 to USD 19.48 Billion by 2033, growing at a CAGR of 18.59% during the forecast period (2026-2033).

The global NGS-based RNA sequencing market is experiencing significant growth driven by technological advancements and increasing clinical demands, shifting transcriptomics into a vital component of clinical medicine. This approach facilitates large-scale quantification of gene expression, alternative splicing, and fusion transcripts, enhancing biomarker discovery, cancer profiling, and drug response monitoring. As sequencing costs continue to decline and throughput improves, the transformation from single gene assays to extensive population projects accelerates translational research, benefiting both academic and commercial sectors. Bioinformatics innovations are also fostering the integration of RNA sequencing into critical applications, such as target validation and patient stratification in pharmaceuticals. AI further enhances this market by automating data analysis and interpretation, allowing researchers to generate insights more efficiently and support the precision medicine paradigm.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ngs-Based Rna-Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ngs-Based Rna-Sequencing Market Segments Analysis

Global ngs-based rna-sequencing market is segmented by service type, outsourcing type, enterprise type, application, industry vertical and region. Based on service type, the market is segmented into RNA Sequencing Services, Library Preparation Services, Data Analysis & Bioinformatics Services, Sample Preparation & QC Services, Custom Sequencing Services, Managed Genomics Services and Others. Based on outsourcing type, the market is segmented into In-house Sequencing, Contract Research Organization (CRO) Outsourcing, Academic & Research Institute Collaboration and Others. Based on enterprise type, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Clinical Laboratories and Others. Based on application, the market is segmented into Transcriptome Profiling, Gene Expression Analysis, Single-cell RNA Sequencing, Epigenetics & Non-coding RNA Analysis, Biomarker Discovery & Drug Development, Clinical Diagnostics and Others. Based on industry vertical, the market is segmented into Healthcare & Clinical Research, Pharmaceutical & Biotechnology, Academic & Government Research, Agriculture & Animal Research and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ngs-Based Rna-Sequencing Market

The growing interest in precision medicine is significantly driving the integration of NGS-based RNA sequencing into diagnostic and therapeutic practices among healthcare providers and researchers. This technology facilitates comprehensive transcriptomic profiling, empowering the formulation of personalized treatment approaches. The uptake of NGS solutions fosters the creation of targeted therapies and biomarkers, leading to increased investment in related platforms and services. As stakeholders place greater emphasis on patient stratification and molecular characterization, the market witnesses a surge in the variety of applications and demand for sequencing technologies. This trend further stimulates innovation among vendors and enhances the accessibility of assay workflows.

Restraints in the Global Ngs-Based Rna-Sequencing Market

The significant investment needed for advanced sequencing technology and the upkeep of supporting infrastructure poses challenges for smaller laboratories and institutions, hindering broader market adoption. The continuous costs associated with reagents, consumables, and service contracts add to the operational pressures, leading to conservative purchasing choices and a focus on existing processes. Financial limitations also restrict investments in new technologies and slow the diversification of service offerings, ultimately impacting the implementation of innovative applications. This scenario creates obstacles in achieving widespread adoption, thereby limiting the overall growth potential of the global NGS-based RNA sequencing market.

Market Trends of the Global Ngs-Based Rna-Sequencing Market

The Global NGS-Based RNA Sequencing market is experiencing a notable trend towards the integration of clinical workflows as healthcare providers increasingly embrace these technologies for diagnostic purposes. This shift is fostering innovative partnerships between laboratory networks and sequencing vendors, aimed at enhancing assay validation and seamless integration with electronic health records. As the scope of NGS-based RNA sequencing broadens, particularly in oncology, rare diseases, and personalized medicine, it not only promotes tailored patient stratification but also facilitates the development of companion diagnostics. This evolving landscape encourages recurring service models and strengthens dialogues around reimbursement, aligning stakeholders around actionable transcriptomic insights.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global NGS-based RNA-sequencing Market Size by Service Type & CAGR (2026-2033)

• Market Overview
• RNA Sequencing Services
• Library Preparation Services
• Data Analysis & Bioinformatics Services
• Sample Preparation & QC Services
• Custom Sequencing Services
• Managed Genomics Services
• Others

Global NGS-based RNA-sequencing Market Size by Outsourcing Type & CAGR (2026-2033)

• Market Overview
• In-house Sequencing
• Contract Research Organization (CRO) Outsourcing
• Academic & Research Institute Collaboration
• Others

Global NGS-based RNA-sequencing Market Size by Enterprise Type & CAGR (2026-2033)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical Laboratories
• Others

Global NGS-based RNA-sequencing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Transcriptome Profiling
• Gene Expression Analysis
• Single-cell RNA Sequencing
• Epigenetics & Non-coding RNA Analysis
• Biomarker Discovery & Drug Development
• Clinical Diagnostics
• Others

Global NGS-based RNA-sequencing Market Size by Industry Vertical & CAGR (2026-2033)

• Market Overview
• Healthcare & Clinical Research
• Pharmaceutical & Biotechnology
• Academic & Government Research
• Agriculture & Animal Research
• Others

Global NGS-based RNA-sequencing Market Size & CAGR (2026-2033)

• North America (Service Type, Outsourcing Type, Enterprise Type, Application, Industry Vertical)
  • US
  • Canada
• Europe (Service Type, Outsourcing Type, Enterprise Type, Application, Industry Vertical)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service Type, Outsourcing Type, Enterprise Type, Application, Industry Vertical)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service Type, Outsourcing Type, Enterprise Type, Application, Industry Vertical)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service Type, Outsourcing Type, Enterprise Type, Application, Industry Vertical)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools Inc. (formerly Fluidigm Corporation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz (Azenta Life Sciences)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations